Latest Insider Transactions at Streamline Health Solutions Inc. (STRM)
This section provides a real-time view of insider transactions for Streamline Health Solutions Inc. (STRM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STREAMLINE HEALTH SOLUTIONS INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STREAMLINE HEALTH SOLUTIONS INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 20
2022
|
Wyche T Green Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+16.58%
|
$150,000
$1.22 P/Share
|
May 20
2022
|
Thomas J. Gibson Former Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+18.46%
|
$90,000
$1.22 P/Share
|
Mar 04
2022
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,850
-2.8%
|
$8,850
$1.38 P/Share
|
Mar 04
2022
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,850
-2.9%
|
$8,850
$1.38 P/Share
|
Mar 04
2022
|
Wyche T Green Iii Director |
SELL
Payment of exercise price or tax liability
|
Direct |
13,275
-2.15%
|
$13,275
$1.38 P/Share
|
Feb 01
2022
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,608
-2.05%
|
$6,608
$1.33 P/Share
|
Jan 29
2022
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,002
-0.97%
|
$3,002
$1.37 P/Share
|
Jan 29
2022
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,814
-0.86%
|
$2,814
$1.37 P/Share
|
Jan 29
2022
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,075
-5.83%
|
$15,075
$1.37 P/Share
|
Dec 16
2021
|
Kenan Lucas Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+2.4%
|
$100,000
$1.5 P/Share
|
Dec 04
2021
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-2.26%
|
$7,525
$1.49 P/Share
|
Dec 04
2021
|
Wyche T Green Iii Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,288
-1.79%
|
$11,288
$1.49 P/Share
|
Dec 04
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-2.38%
|
$7,525
$1.49 P/Share
|
Dec 04
2021
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-2.83%
|
$7,525
$1.49 P/Share
|
Sep 10
2021
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,512
-3.06%
|
$10,512
$1.8 P/Share
|
Sep 04
2021
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,810
-2.22%
|
$7,810
$1.76 P/Share
|
Sep 04
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-2.33%
|
$7,525
$1.76 P/Share
|
Sep 04
2021
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-2.75%
|
$7,525
$1.76 P/Share
|
Sep 04
2021
|
Wyche T Green Iii Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,288
-1.76%
|
$11,288
$1.76 P/Share
|
Jun 17
2021
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,526
-2.1%
|
$7,526
$1.85 P/Share
|
Jun 17
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,526
-2.27%
|
$7,526
$1.85 P/Share
|
Jun 17
2021
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,526
-2.68%
|
$7,526
$1.85 P/Share
|
Jun 04
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,526
-2.22%
|
$7,526
$1.93 P/Share
|
Jun 04
2021
|
Wyche T Green Iii Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,288
-1.73%
|
$11,288
$1.93 P/Share
|
Jun 04
2021
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,526
-2.05%
|
$7,526
$1.93 P/Share
|
Jun 04
2021
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,526
-2.61%
|
$7,526
$1.93 P/Share
|
May 20
2021
|
Justin John Ferayorni Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+20.81%
|
$75,000
$2.0 P/Share
|
May 20
2021
|
Judith Starkey Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+7.3%
|
$75,000
$2.0 P/Share
|
May 20
2021
|
Jonathan R Phillips Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+3.91%
|
$75,000
$2.0 P/Share
|
Mar 17
2021
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,407
-1.98%
|
$14,814
$2.26 P/Share
|
Mar 17
2021
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,874
-2.51%
|
$29,748
$2.26 P/Share
|
Mar 17
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-2.17%
|
$15,050
$2.26 P/Share
|
Mar 04
2021
|
Wyche T Green Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+18.71%
|
-
|
Mar 04
2021
|
Thomas J. Gibson Former Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+21.09%
|
-
|
Mar 04
2021
|
William George Garvis SVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+25.25%
|
-
|
Mar 04
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+22.41%
|
-
|
Mar 02
2021
|
Tamarack Global Healthcare Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
625,000
+11.25%
|
$625,000
$1.6 P/Share
|
Mar 02
2021
|
Tamarack Global Healthcare Fund, L.P. > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
625,000
+12.89%
|
$625,000
$1.6 P/Share
|
Mar 02
2021
|
Wyche T Green Iii Director |
BUY
Grant, award, or other acquisition
|
Indirect |
250,000
+50.0%
|
$250,000
$1.6 P/Share
|
Mar 02
2021
|
Jonathan R Phillips Director |
BUY
Grant, award, or other acquisition
|
Indirect |
62,500
+46.3%
|
$62,500
$1.6 P/Share
|
Mar 02
2021
|
Judith Starkey Director |
BUY
Grant, award, or other acquisition
|
Indirect |
62,500
+50.0%
|
$62,500
$1.6 P/Share
|
Mar 02
2021
|
Justin John Ferayorni Director |
BUY
Grant, award, or other acquisition
|
Indirect |
625,000
+50.0%
|
$625,000
$1.6 P/Share
|
Mar 02
2021
|
Kenan Lucas Director |
BUY
Grant, award, or other acquisition
|
Indirect |
625,000
+13.61%
|
$625,000
$1.6 P/Share
|
Feb 01
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,850
-3.47%
|
$17,700
$2.02 P/Share
|
Jan 29
2021
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,683
-5.63%
|
$11,683
$1.85 P/Share
|
Jan 29
2021
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,921
-1.03%
|
$2,921
$1.85 P/Share
|
Jan 29
2021
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,921
-1.13%
|
$2,921
$1.85 P/Share
|
Dec 17
2020
|
William George Garvis SVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-3.5%
|
$7,525
$1.68 P/Share
|
Dec 17
2020
|
Thomas J. Gibson Former Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-2.59%
|
$7,525
$1.68 P/Share
|
Dec 17
2020
|
Randolph Salisbury SVP,Chief Sales & Mktg Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,525
-2.83%
|
$7,525
$1.68 P/Share
|